MedPath

Treatment of Moderate to Severe Lateral Canthal Lines

Phase 3
Completed
Conditions
Lateral Canthal Lines
Registration Number
NCT04249687
Lead Sponsor
Galderma R&D
Brief Summary

The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe LCL.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
303
Inclusion Criteria
  1. Male or female 18 years of age or older.
  2. Moderate to severe LCL at maximum smile as assessed by the Investigator.
  3. Moderate to severe LCL at maximum smile as assessed by the subject.
Exclusion Criteria
  1. Previous use of any Botulinum toxin treatment in facial areas within 9 months prior to study treatment.
  2. Female who is pregnant, breast feeding, or intends to conceive a child during the study.
  3. Known allergy or hypersensitivity to any component of the investigational product (QM1114-DP) or any botulinum toxin serotype.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of Subjects With a ≥ 2-grade Improvement From Baseline on the Lateral Canthal Line Investigator and Subject Assessments at Maximum Smile at One Month.Month 1

The investigator and subject evaluate the subject's LCL severity using a 4-grade scale (0 = none and 3 = severe)

Secondary Outcome Measures
NameTimeMethod
Percentage of Subjects Who Achieve Grade 0 or 1 in Lateral Canthal Line Investigator Scale at Maximum Smile.One Month

Trial Locations

Locations (10)

Ablon Skin Institute and Research Center

🇺🇸

Manhattan Beach, California, United States

Dermatology Cosmetic Laser Medical Associates

🇺🇸

San Diego, California, United States

Art of Skin, MD

🇺🇸

Solana Beach, California, United States

Siperstein Dermatology Group, PLLC

🇺🇸

Boynton Beach, Florida, United States

Facial Plastic Surgicenter, Ltd

🇺🇸

Baltimore, Maryland, United States

The Center for Dermatology, Cosmetic & Laser Surgery

🇺🇸

Mount Kisco, New York, United States

Rochester Dermatologic Surgery, Ltd

🇺🇸

Victor, New York, United States

Aesthetic Solutions, PA

🇺🇸

Chapel Hill, North Carolina, United States

Dr. Shannon Humphrey, Inc

🇨🇦

Vancouver, British Columbia, Canada

Pacific Dermaesthetics, Inc

🇨🇦

Vancouver, British Columbia, Canada

Ablon Skin Institute and Research Center
🇺🇸Manhattan Beach, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.